Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab

INTRODUCTION: Infliximab is an effective treatment for inflammatory bowel disease (IBD). Studies differ regarding the influence of body mass index (BMI) on the response to infliximab, with the majority of studies indicating that increased BMI may be associated with a poorer response to Infliximab. H...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Scaldaferri, Franco, D‘Ambrosio, Daria, Holleran, Grainne, Poscia, Andrea, Petito, Valentina, Lopetuso, Loris, Graziani, Cristina, Laterza, Lucrezia, Pistone, Maria Teresa, Pecere, Silvia, Currò, Diego, Gaetani, Eleonora, Armuzzi, Alessandro, Papa, Alfredo, Cammarota, Giovanni, Gasbarrini, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657978/
https://ncbi.nlm.nih.gov/pubmed/29073159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0186575
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados